Translational Research (TR) Company, a division of Shin Nippon Biomedical Laboratories, Ltd (SNBL), has developed an exclusive technology for nasal drug delivery, the μco™ system (“myu-co” system). This system comprises two technological elements: powder carrier technology and delivery device technology. In addition to licensing this platform technology and internally developed products to pharmaceutical companies, SNBL supports the research and development of pharmaceutical products. They leverage the Group's extensive experience and capabilities in drug development as a Contract Research Organization (CRO), and utilize their world-renowned state-of-the-art preclinical and clinical study facilities.
Servicing and Logistics
Remma and its partners provide you with serviced and configured equipment tailored to your needs. Receive your product at your facility with standard or express delivery, and an installation option, all through a single point of contact.
Warranty
Our 12/24-month warranty ensures the safety and reliability of your medical equipment throughout its lifespan.
Flexible Financing
Settle your medical equipment in up to 36 installments with our financing service or pay after delivery with Remma Facility.